CClinicalTrials.gg
Sign In
Status unknownNCT00237978Updated May 14, 2009

Control of Therapy of Acne Papulopustulosa by Visible Light With Waterfiltered Infrared and / or Adapalen (Differin Gel)

A Phase 4 interventional study of Adapalen and VIS and wIRA in Acne Papulopustulosa, sponsored by Technische Universität Dresden. Status unknown at 1 site in Germany. Open to participants aged 14 Years and older. Per ClinicalTrials.gov, last updated 2009-05-14.

Sponsored by Technische Universität Dresden · Phase 4, Interventional, and Treatment

The sponsor has not verified this record recently (last verified May 2008), so the status shown — last known as Recruiting — may be out of date.
Phase
Phase 4
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
14 Years and older
Sex
All
01

Study summary

The aim of the study is to investigate the effectivity of visible light in combination with waterfiltered infrared in treating acne papulopustulosa. The reduction of inflammatory and non-inflammatory lesions within 8 weeks will be measured and compared with the standard treatment with Adapalene.

02

Conditions studied

  • Acne Papulopustulosa

Browse trials for

03

In context

Acne Vulgaris

730 studies on the registry are indexed under Acne Vulgaris; 86 are open to participants now.

This study's planned enrollment of 60 is below the median of 69 across 628 interventional studies indexed under Acne Vulgaris.

Browse Acne Vulgaris studies →

Lead sponsor

Technische Universität Dresden is the lead sponsor of 237 studies on the registry; 45 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Mild to moderate acne papulopustulosa according to Burton Scale Stage 3 to 4
  • At least 5 inflammatory and 5 non-inflammatory lesions in the face
  • Age >= 14 years

Exclusion criteria

Exclusion Criteria:

  • pregnant and nursing women
  • Antiandrogen therapy
  • therapy with antibiotics within the last 4 weeks
  • therapy with retinoids within the last 6 months
  • natural or artificial UV-therapy within the last 4 weeks
  • severe acne papulopustulosa according to Burton Scale 5 or 6
  • Severe systemic condition
  • Secondary acne
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    1

    VIS and wIRA

    Radiation: VIS and wIRA

  • Active comparator
    2

    VIS, wIRA and Adapalen

    Drug: Adapalen · Radiation: VIS and wIRA

  • Active comparator
    3

    Adapalen

    Drug: Adapalen

Interventions

  • DrugAdapalen
  • RadiationVIS and wIRA
06

What researchers measure

Primary outcomes

  1. reduction of inflammatory and non-inflammatory lesions within 8 weeks after start of therapy

07

Study locations

1 of 1 sites recruiting
  • Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden
    Dresden, Sachsen 01307, Germany
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 14, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00237978
Lead sponsor
Technische Universität Dresden
First posted
Oct 13, 2005
Start date
Sep 2006
Primary completion
Jun 2009 (estimated)
Completion
Sep 2009 (estimated)
Last update
May 14, 2009

Study contacts

Roland Aschoff, MD
Contact
Roland.Aschoff@mailbox.tu-dresden.de
0049-351-458 ext. 2007
Roland Aschoff, MD
principal investigator · Technische Universität Dresden, Fetscher Str. 74, 01307 Dresden, Germany

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Acne Vulgaris→

Other studies from this sponsor

Technische Universität Dresden

Start the discussion